• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • China’s Medical Device Supplementary Notice Period reverts to a one-year period

China’s Medical Device Supplementary Notice Period reverts to a one-year period

Medical Device Supplementary Notice Period
Wednesday, 29 March 2023 / Published in Medical Device, News, NMPA Registration in China

China’s Medical Device Supplementary Notice Period reverts to a one-year period

China’s Medical Device Supplementary Notice Period reverts to a one-year period following its temporary extension to a 2-year period.

As part of the Chinese government’s ongoing efforts to adjust registration processes during the Coronavirus epidemic, the National Medical Products Administration (NMPA) had granted an additional one-year extension to provide supplementary information. The supplementary notice requires medical device manufacturers to submit additional supporting information for their medical device registration applications.

This additional one-year extension has now been withdrawn as the China moves back to normality.

This means that:

  • if a Medical Device Supplementary Information Notice is received from the NMPA before February 20, 2023, the period for providing the supplementary information is 2 years – the initial year plus a one-year extension
  • if a Medical Device Supplementary Information Notice is received from the NMPA on or after February 20, 2023, the time limit for providing the supplementary information is 1 year only.

It is important to be aware of these changes and to actively prepare the necessary supplementary information, should you receive a notification from the NMPA. This will help to ensure timely submission of relevant information otherwise the registration application will be rejected. This clearly has implications for medical device and IVD manufacturers who are asked to undertake long-term tests or supplementary clinical trials.

The process should you receive a request for Supplementary Information is:

  1. The NMPA will only issue a Supplementary Notice Request once
  2. After receiving the NMPA’s request, registration applicants must submit the supporting additional documents for completeness in one go within the time limit of one year
  3. Applicants can request up to three online consultation meetings with the NMPA during the one-year period
  4. Before the final submission, registration applicants are allowed to request a Pre-Assessment from NMPA.

Further information

Read the original CMDE announcement on medical device supplementary notice period adjustments in China.

At Cisema, we understand the complexity of navigating these regulatory changes and the importance of compliance with all requirements. Our team of experts can provide guidance and support to ensure that your medical device registration and filing processes run smoothly and successfully in China.

Stay informed and up-to-date with the latest regulatory changes to ensure the continued success of your medical device products in the Chinese market.

GET IN TOUCH

🌐 Send us your enquiry
📚 Request our whitepapers
📣 Sign up for our newsletter

What you can read next

China drug registration evaluation
China drug registration evaluation report 2021 released
Measures for the supervision and administration of drug production
Measures for the Supervision and Administration of Drug Production in China – A Recap
china class I medical device filing
China class I medical device filing clarification

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China health food regulatory updates

    China health food regulatory updates in August 2023

    China health food regulatory updates were annou...
  • Children cosmetics technical guidelines in China

    Children cosmetics technical guidelines in China – Newly issued by NIFDC

    Children cosmetics technical guidelines in Chin...
  • pH Determination Method

    China’s cosmetic safety technical specifications – 21 revision items issued

    China’s cosmetic safety technical specifi...
  • laser therapy devices

    Clinical evaluation of laser therapy devices – New guidelines issued

    Clinical evaluation of laser therapy devices ha...
  • dental implant system

    Clinical evaluation of dental implant systems in China – New guidelines issued

    Clinical evaluation of dental implant system ha...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2003-2023 Cisema. All rights reserved.

TOP